Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page footer.
    Difference
    0.1%
    Check dated 2026-03-11T12:05:10.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and notices for Revision: v3.4.1 and the government funding lapse were removed.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:56.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the revision label to v3.4.1. The previous revision label v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:24:20.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:39:17.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no study content or endpoints were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:31:27.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page's location information section was updated: 'Texas Locations' was replaced with a general 'Locations' section and a 'Texas' entry added; the 'HHS Vulnerability Disclosure' link was removed, and the page revision advanced from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:59:17.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.